[Inflammatory bowel diseases: an immunological approach]
- PMID: 18575665
[Inflammatory bowel diseases: an immunological approach]
Abstract
Inflammatory bowel diseases (IBD) are inflammatory diseases with a multifactorial component that involve the intestinal tract. The two relevant IBD syndromes are Crohn's disease (CD) and ulcerative colitis (UC). One factor involved in IBD development is a genetic predisposition, associated to NOD2/CARD15 and Toll-like receptor 4 (TLR4) polymorphisms that might favor infectious enterocolitis that is possibly associated to the development of IBD. The identification of specific immunologic alterations in IBD and their relationship to the etiology of the disease is a relevant research topic. The role of intra and extracellular molecules, such as transcription factors and cytokines that are involved in the inflammatory response, needs to be understood. The relevance of immunologic molecules that might drive the immune response to a T helper (Th) 1, Th 2 or the recently described Th 17 phenotype, has been demonstrated in animal models and clinical studies with IBD patients. CD and UC predominantly behave with a Th 1 and Th 2 immune phenotype, respectively. Recently, an association between CD and Th 17 has been reported. The knowledge acquired from immunologic and molecular research will help to develop accurate diagnostic methods and efficient therapies.
Similar articles
-
NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.Eur Cytokine Netw. 2006 Jun;17(2):125-30. Eur Cytokine Netw. 2006. PMID: 16840031
-
New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.Am J Gastroenterol. 2008 Mar;103(3):665-81. doi: 10.1111/j.1572-0241.2007.01652.x. Epub 2007 Nov 28. Am J Gastroenterol. 2008. PMID: 18047543
-
Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.Scand J Gastroenterol. 2007 Jul;42(7):827-33. doi: 10.1080/00365520601114024. Scand J Gastroenterol. 2007. PMID: 17558906
-
Advances in the molecular dissection of inflammatory bowel disease.Semin Immunol. 2006 Aug;18(4):244-53. doi: 10.1016/j.smim.2006.03.012. Epub 2006 May 5. Semin Immunol. 2006. PMID: 16679026 Review.
-
Review article: Inflammatory bowel disease and genetics.Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:57-65. doi: 10.1111/j.1365-2036.2007.03476.x. Aliment Pharmacol Ther. 2007. PMID: 18081650 Review.
Cited by
-
Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease.Microb Cell. 2021 Jun 18;8(9):223-238. doi: 10.15698/mic2021.09.760. eCollection 2021 Sep 6. Microb Cell. 2021. PMID: 34527721 Free PMC article.
-
Mechanism of regulation of Na-H exchanger in inflammatory bowel disease: role of TLR-4 signaling mechanism.Dig Dis Sci. 2011 Jun;56(6):1656-62. doi: 10.1007/s10620-010-1524-7. Epub 2011 Jan 8. Dig Dis Sci. 2011. PMID: 21221801
-
B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.Dig Dis Sci. 2016 Sep;61(9):2608-18. doi: 10.1007/s10620-016-4136-z. Epub 2016 Apr 7. Dig Dis Sci. 2016. PMID: 27056038
-
Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease.Parasit Vectors. 2011 Sep 27;4:186. doi: 10.1186/1756-3305-4-186. Parasit Vectors. 2011. PMID: 21943110 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources